Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Veterinary Antibiotics Market, by Product Type (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, and Others), by End Use (Dairy Farm, Poultry Farm, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Published Date : Dec 2018

Veterinary Antibiotics Market – Insights Veterinary antibiotics combat infections caused by bacteria. Antibiotics are used for a variety of purposes in the farming of livestock, including therapeutic an

Coherent Market Insights
Ciclesonide Market, by Indication (Asthma and Allergic Rhinitis), by Dosage Form (Aerosol and Nasal Spray), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published Date : Nov 2018

Ciclesonide Market - Insights Ciclesonide, are used to prevent the difficulty in breathing, chest tightness, wheezing, and coughing caused by asthma in adults and children 12 years of age and older. It works as a being class of corticost

Coherent Market Insights
Nonalcoholic Steatohepatitis Treatment Market, By Drug (Cenicriviroc, Elafibranor, Ocaliva, and Selonsertib), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

Published Date : Nov 2018

Nonalcoholic Steatohepatitis Treatment Market – Insights Nonalcoholic steatohepatitis (NASH) is a form of nonalcoholic fatty liver disease (NAFLD) in which a person have hepatitis and inflammation of th

Coherent Market Insights
Resveratrol Market, by Application (Cosmetics, Dietary Supplements, Pharmaceutical, and Others), by Dosage Form (Tablet, Capsule, and Liquid), by Distribution Channel (Retail Channel, Online Channels and Others),  and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Published Date : Nov 2018

Resveratrol Market - Insights Resveratrol is a flavonol belonging to the group of flavonoids. It is a phytoalexin synthesized naturally by various plants when attacked by various pathogens such as bacteria or

Coherent Market Insights
Calciphylaxis Treatment Market, by Treatment (Drug Therapy, and Hyperbaric Oxygen Therapy), by End User (Hospital and Clinics, Homecare, and Ambulatory Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Published Date : Oct 2018

Calciphylaxis Treatment Market – Insights Calciphylaxis or Calcific Uremic Arteriolopathy (CUA) is the most severe form of cardiovascular calcification in dialysis patients. It starts with a calcificati

Coherent Market Insights
Halitosis Treatment Market, by Type (Pathological and Non-pathological), by Treatment (Antacids, Antiseptics, Antiplaque, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Published Date : Oct 2018

Halitosis Treatment Market – Insights Halitosis or bad breath is a common problem that can cause significant psychological distress. There are a number of potential causes and treatments available for h

Coherent Market Insights
Ursodeoxycholic Acid Market, by Dosage Form (Solid and Liquid), by Mode of Extraction (Synthetic and Biological), by Application (Gallstones, Cystic Fibrosis, Liver Cirrhosis, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Published Date : Oct 2018

Ursodeoxycholic Acid Market – Insights Ursodeoxycholic acid (UDCA) is a bile acid taken as either a tablet or liquid to treat gallstones and to treat and prevent the progression of cystic fibrosis-relat

Coherent Market Insights
Saline Laxatives Market, by Age Group (Pediatric and Adult), by Route of Administration (Oral and Rectal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026

Published Date : Oct 2018

Saline Laxatives Market – Insights Saline laxatives are soluble inorganic salts that contain multivalent cations or anions. Examples of saline laxatives include citrate salts (Royvac), magnesium prepara

Coherent Market Insights
Hydrocortisone Market, by Product Type (Injection, Cream/Ointment, Tablet, and Others), By Indication (Adrenocortical Insufficiency, Allergic Conditions, Arthritis, COPD/Asthma, Cancer, and Others), by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Dec 2018

Hydrocortisone is the medical name of hormone, corticosteroid. Naturally corticosteroid is made by adrenal gland inside adrenal cortex. Medicinally, hydrocortisone is used in various conditions such as allergic reactions (itching, swelling, redness), arthritis, neurol

Coherent Market Insights
CpG Oligodeoxynucleotide Market, by Source (Natural Source and Chemical Synthesis), by End User (Research Institutes, Hospitals, Contract Research Organizations, Pharmaceutical Companies, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Dec 2018

CpG oligodeoxynucleotide (CpG ODN) is a synthetic oligodeoxynucleotide, which contains unmethylated CpG motifs derived from bacterial DNA with immunostimulatory activities. CpG ODN is a short single-stranded synthetic DNA molecule, which contains one of each of cytosi

Coherent Market Insights
Sucralfate Market, by Formulation (Tablet and Liquid), by Indication (Gastric Ulcers, Duodenal Ulcers, Gastro Esophageal Reflux Disease (GERD), and Other Indications), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Dec 2018

Sucralfate is the generic form of the brand-name drug, Carafate. It is a prescription medicine used to treat ulcers of the upper gastrointestinal tract, peptic ulcer disease, and to prevent reoccurrence of ulcers. Sucralfate is a hydroxy aluminum salt of sucrose octas

Coherent Market Insights
Streptozocin Market by Product Type (Powder and Solution), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Dec 2018

Streptozocin is a drug approved by U.S. Food and Drug Administration (USFDA) for the treatment of pancreatic islet cells cancer. Streptozocin is classified as an alkylating agent, which produces anti-cancer effects by causing a chemical reaction that damages the DNA i

Coherent Market Insights
Quercetin Dihydrate Market, by Product Type (Powder and Solution), by Application, (Atherosclerosis, Chronic Infections, Cosmetics, Nutraceuticals, Allergy & Inflammation, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Dec 2018

Quercetin is a plant flavonoid found in variety of fruits, vegetables, grains, and leaves. It is used as an ingredient in nutritional supplements and prepared foods. Quercetin dihydrate is formed by removing moisture from quercetin, which is more effective and highly

Coherent Market Insights
Poliomycetes Vaccine in Dragee Candy Market, by Vaccine Type (Type I Poliovirus Infection, and Type II Poliovirus Infection), by Application (Hospitals, Clinics, and Medical Centers), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Dec 2018

Poliomyelitis is an acute communicable disease of humans caused by human enterovirus called poliovirus. Poliovirus is transmitted from one person to another by oral contact, with secretions or fecal material from an infected person. Wild type poliovirus cases have bee

Coherent Market Insights
Pharma Grade Magnesium Trisilicate Market by Product Type (heavy and Light), by Application (Pharmaceuticals, Cosmetics, Food, and Industrial), and by Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

To Be Published : Dec 2018

Magnesium trisilicate is an inorganic compound that is used as Active Pharmaceutical Ingredient (API) in an antacid formulations for the treatment of peptic ulcers. The gelatinous silicon dioxide is formed by the reaction of magnesium trisilicate with gastric contents

Coherent Market Insights
Polyether Antibiotics Market, by Drug (Lasalocid, Monesin, Salinomycin, Narasin, and Others), by Application (Coccidiosis, Growth Promotion in Cattles, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Dec 2018

Polyether ionophores antibiotics group consists of natural, biologically active substances produced by Streptomyces spp species. Polyether antibiotics have antifungal, antibacterial, antiviral, antiparasitic, and tumor cell cytotoxicity properties. Commercially, polye

Coherent Market Insights
Tacrolimus Market, by Product Type (Tacrolimus Capsules & Tablets, Tacrolimus Ointment, and Tacrolimus Injection), by Application (Immunosuppression, Dermatitis, and Others), by End User (Organ Transplant Centers, Hospitals, and Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Dec 2018

Tacrolimus is used as an immunosuppressant mainly after organ transplant procedures to prevent organ rejection. Tacrolimus inhibits the activation of serine-threonine phosphatase, calcineurin, in T lymphocytes. This suppresses T lymphocyte activation and the subs

Coherent Market Insights
Codeine Market, by Indication (Pain Management, and Cough Management), by Age Group (Adult and Pediatric), by Dosage Form (Tablet, Capsule and Solution/Syrup), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Dec 2018

Codeine is a drug of class known as opioids, widely used in the treatment and management of mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu (when combined with antihistamines and decongestants). Opioids interact with opioid recepto

Coherent Market Insights
Nitric Oxide Synthase (NOS) Brain Market, by Product Type (Neuronal NOS (nNOS), Endothelial NOS (eNOS), and Inducible NOS (iNOS)), by End User (Research Institutes, Biotechnology and Pharmaceutical Companies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

To Be Published : Dec 2018

Nitric oxide synthases (NOS) are group of enzymes, which convert L-arginine to L-citrulline and produce nitric oxide (NO). Nitric oxide synthases enzymes exhibit a bidomain structure homologous to cytochrome P450 reductase. There are three isoforms of NOS titled accor

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.